Sato E[31] had verified CXCL10 was an inhibitor to growth and metastases in tumor, and different expression level in CRC patients had different prognostic [32] In Jessicca D. Abron’s study, he investigated the role of CXCR3 in inflammation and colorectal cancer. This evidence concerns the gene CXCR3 and colorectal carcinoma.